Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on UK Healthcare Gazette.
Press releases published on July 21, 2025

The Documentary Channel and UnchainedTV Partner to Spotlight Urgent Environmental and Social Justice Issues
The newly relaunched streaming service Documentary Channel is proud to announce a strategic partnership with UnchainedTV, a trailblazing platform. HOLLYWOOD, CA, UNITED STATES, July 21, 2025 /EINPresswire.com/ -- The newly relaunched streaming service, …

Creative Diagnostics Launches HIV Infection Rhesus Monkey Models to Accelerate AIDS Research and Treatment Development
Creative Diagnostics announces highly specialized HIV Infection Rhesus Monkey Models to accelerate HIV/AIDS research. NEW YORK, NY, UNITED STATES, July 21, 2025 /EINPresswire.com/ -- As an expert in providing solutions to assist virology and …

FormaTK Systems Achieves Full EU MDR Certification – Reinforcing Commitment to Quality and Innovation
TIRAT CARMEL, HAIFA DISTRICT, ISRAEL, July 21, 2025 /EINPresswire.com/ -- FormaTK Systems Ltd., a global developer and manufacturer of advanced aesthetic medical technologies, proudly announces that it has been officially certified under the European …

Never Give Up Day — The Celebration the World Was Waiting For
Once an idea, now a global movement, Never Give Up Day is quickly becoming the emotional anchor the modern world embraces. NEW YORK, NY, UNITED STATES, July 21, 2025 /EINPresswire.com/ -- Celebrated each year on August 18, Never Give Up Day has emerged …

Creative Diagnostics Announces New Antibody Pairs for Enhanced Human Metapneumovirus (hMPV) Detection
Creative Diagnostics launches high-performance antibody pairs and antigens for the detection of hMPV. NEW YORK, NY, UNITED STATES, July 21, 2025 /EINPresswire.com/ -- Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and …

Infopro Learning Named to Training Industry’s 2025 Top 20 AI Coaching & Learner Support Tools Companies List
Infopro Learning honored for AI coaching tools that enable adaptive learning, real-time support, and workforce transformation. PLAINSBORO, NJ, UNITED STATES, July 21, 2025 /EINPresswire.com/ -- Infopro Learning has been named to the 2025 Top AI Coaching …

ancora Software Expands Healthcare Presence in First Half of 2025 with 24 New Hospital Clients, Including 14 in the UK
ancora Software adds 24 hospital clients—14 in the UK—boosting global healthcare growth with its AP automation and IDP technology. SAN DIEGO, CA, UNITED STATES, July 21, 2025 /EINPresswire.com/ -- ancora Software, Inc., a leading provider of Intelligent …

How a Hidden Hand of Hepatic Signaling Could Help Fight Metabolic Disease
New research identifies PTPRD as a key regulator of metabolic liver disease – making it a potential target for treating diseases such as MASLD and MASH. CHINA, July 21, 2025 /EINPresswire.com/ -- Chronic liver diseases tied to metabolic dysfunction— …

Intrinseque Health Officially Launches Malaysia Entity in Melaka
Intrinseque Health is proud to announce the official inauguration of its new entity, Intrinseque Health (Malaysia) Sdn. Bhd. MELAKA, MALAYSIA, July 21, 2025 /EINPresswire.com/ -- Intrinseque Health is proud to announce the official inauguration of its …

Introducing Jeeva 2.0: The Agentic AI Platform Boosting GTM Sales Productivity Tenfold
Jeeva 2.0 launches with advanced agentic AI to streamline sales tasks, enhance personalization, and drive 10x productivity for GTM teams. SANTA MONICA, CA, UNITED STATES, July 21, 2025 /EINPresswire.com/ -- Jeeva AI, a leading agentic AI sales platform, …

George Medicines signs exclusive licensing agreement with Azurity Pharmaceuticals to commercialize WIDAPLIK™ (telmisartan, amlodipine and indapamide) tablets in the US
George Medicines signs exclusive licensing agreement with Azurity Pharmaceuticals to commercialize WIDAPLIK™ (telmisartan, amlodipine and indapamide) tablets in the US An innovative single pill combination of three medicines, including two doses that are …

Tiziana Life Sciences Announces Immunologic Analysis of Nasal Foralumab in Moderate Alzheimer's Patient
NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …